Skip to main content

Day: December 24, 2022

Operations Update and Initiation of Arbitration

CALGARY, Alberta, Dec. 24, 2022 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura”) is pleased to announce today that repair and testing of the Zarghun South sale gas pipeline, which was damaged due to flash floods, have been completed and the supply of sale gas has resumed from the Zarghun South Lease. The Zarghun South Lease covers an area of 124.22 square kilometers in the western part of the Sulaiman Fold and Thrust Belt of the Middle Indus Basin. It is strategically located near the gas demand centre of the city of Quetta. Jura holds a 40% working interest in the Zarghun South Lease, which is operated by Mari Petroleum Company Limited. Jura also provides an update with regard to a dispute between its wholly-owned subsidiaries, Spud Energy Pty Limited (“SEPL”) and Frontier Holdings Limited (“FHL”), with Petroleum Exploration...

Continue reading

LPI Completes Maricunga Ownership Consolidation

HIGHLIGHTSLPI has now completed the Bearing Transaction to acquire the final 17.14% interest in Maricunga LPI has now consolidated ownership of 100% of MaricungaSYDNEY, Australia, Dec. 24, 2022 (GLOBE NEWSWIRE) — Lithium Power International Limited (ASX: LPI) (“LPI” or the “Company”) is pleased to advise that it has now successfully completed the Plan of Arrangement with joint venture partner Bearing Lithium Corp. (BRZ:TSXV) (“Bearing Transaction”) who held a 17.14% interest in the Maricunga lithium brine project in Chile (“Maricunga”). As announced on 20 December, the Company completed the merger with Salar Blanco, LLC to acquire the 31.31% of Maricunga which was held by joint venture partner Minera Salar Blanco SpA (“SBD Transaction”) (together with the Bearing Transaction, the “Transactions”). As a result of the Transactions...

Continue reading

Correction: Awilco Drilling PLC: Mandatory notification of trade – primary insiders

Reference is made to the stock exchange announcement by Awilco Drilling PLC (the “Company”) published on 21 December 2022, regarding the successful private placement of new Sponsored Norwegian Depository Receipts in the Company (the “Private Placement”). Certain of the Company’s primary insiders and their close associates have subscribed and been allocated new Sponsored Norwegian Depository Receipts in the Private Placement as further described in the attached forms. Aberdeen, 24 December 2022   For further information please contact: Erik Jacobs, CEO of Awilco Drilling; Tel: +44 1224 737900Cathrine Haavind, Investor Relations of Awilco Drilling; Tel: +47 93 42 84 64, ch@awilcodrilling.com This information is subject to the disclosure requirements in Article 19 of MAR (Regulation (EU) No. 596/2014 on market...

Continue reading

Coherus and Junshi Biosciences Share Update on the FDA Review of the Biologics License Application (BLA) for Toripalimab as Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC)

– FDA has been unable to travel to China to conduct the required site inspection resulting in delayed action on the BLA – – Coherus and Junshi Biosciences are actively engaged in ongoing discussions with the FDA to support the inspections and gain approval of toripalimab for patients with NPC in the U.S. as quickly as possible – SHANGHAI, China, and REDWOOD CITY, Calif., Dec. 24, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) today announced that the companies have not received an action letter from the U.S. Food and Drug Administration (FDA, the Agency) regarding the Biologics License Application (BLA) for toripalimab in combination with chemotherapy as treatment for recurrent or metastatic...

Continue reading

PlantX Announces Filing of Restated Financial Statements for the Year Ended March 31, 2021 and Filing of the Annual Financial Statements for the Year Ended March 31, 2022

VANCOUVER, British Columbia, Dec. 23, 2022 (GLOBE NEWSWIRE) — PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company“), the digital face of the plant-based community, operating a one-stop shop for plant-based products, announces the filing of its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021 (the “Restated Financial Statements“) and the filing of its annual financial statements for the year ended March 31, 2022 along with its associated management’s discussion and analysis and related officer certifications (the “Annual Filings“). The Restated Financial Statements and the Annual Filings are available under the Company’s SEDAR profile at www.sedar.com. Highlights...

Continue reading

ER Fitch Pty Ltd Acquires Securities of Class 1 Nickel & Technologies Limited

NOT FOR DISTRIBUTION OR DISSEMINATION INTO THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — ER Fitch Pty Ltd. ATF Eloise Fitch Family Trust (the “Acquirer”) announces that it has acquired ownership and control of convertible debentures (the “Debentures”) of Class 1 Nickel & Technologies Limited (the “Company” or “Class 1”), effective December 23, 2022 (the “Acquisition”). The Debentures are convertible in accordance with the terms thereof into up to 4,545,454 common shares of the Company (the “Underlying Shares“) at a deemed price of $0.11 per share. The Underlying Shares were issued pursuant to a private placement by the Company and represent approximately 3% of all issued and outstanding common shares of the Company (“Shares”) as of December 23, 2022 on a partially...

Continue reading

Medivolve Announces CAN $1.2 Million Convertible Note Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Dec. 23, 2022 (GLOBE NEWSWIRE) — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; FRA:4NC), a healthcare technology and services company, today announced a secured convertible note financing in the amount of CAN $1.2 million, which includes a CAN $200,000 original issue discount (“OID”). CAN $1.2 Million Secured Convertible Note This investment will be in the form of a secured convertible note (the “Note”) with a face value of CAN $1.4 million, for aggregate gross proceeds to the Company of CAN $1.2 million after deduction of the OID. Cumulative interest on the outstanding principal amount shall be payable at the annual rate of 8.0% per annum. The Note is expected to mature on December 31, 2023 and will be convertible,...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.